Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Microbiology 142 (1996), 1965-1972
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ylihonko, K.
Right arrow Articles by Mantsala, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ylihonko, K.
Right arrow Articles by Mantsala, P.
Agricola
Right arrow Articles by Ylihonko, K.
Right arrow Articles by Mantsala, P.

microbiology, Vol 142, 1965-1972, Copyright © 1996 by Society for General Microbiology

ARTICLES

Production of hybrid anthracycline antibiotics by heterologous expression of Streptomyces nogalater nogalamycin biosynthesis genes

K Ylihonko, J Hakala, T Kunnari and P Mantsala
Department of Biochemistry and Food Chemistry, University of Turku, Finland. kylihonk@finabo.abo.fi

A cluster of anthracycline biosynthetic genes isolated from Streptomyces nogalater was expressed in Streptomyces lividans and in Streptomyces galilaeus. A 12 kb DNA fragment cloned from this cluster in pIJ486 caused the production of a novel compound when introduced into S. lividans. The compound is derived from nogalonic acid methyl ester, an early intermediate in nogalamycin biosynthesis. Complementation with the cloned 12 kb fragment of S. galilaeus mutants blocked in aclacinomycin biosynthesis caused the production of hybrid anthracyclines. Cloning of the nogalamycin gene cluster should make possible a detailed study of the biosynthesis of this interesting antibiotic, as well as the production of novel anthracyclines of potential value as cytostatic drugs.


This article has been cited by other articles:


Home page
 MicrobiologyHome page
K. Raty, A. Hautala, S. Torkkell, J. Kantola, P. Mantsala, J. Hakala, and K. Ylihonko
Characterization of mutations in aclacinomycin A-non-producing Streptomyces galilaeus strains with altered glycosylation patterns
Microbiology, November 1, 2002; 148(11): 3375 - 3384.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Torkkell, T. Kunnari, K. Palmu, J. Hakala, P. Mäntsälä, and K. Ylihonko
Identification of a Cyclase Gene Dictating the C-9 Stereochemistry of Anthracyclines from Streptomyces nogalater
Antimicrob. Agents Chemother., February 1, 2000; 44(2): 396 - 399.
[Abstract] [Full Text]

Home page
 MicrobiologyHome page
J. Kantola, T. Kunnari, A. Hautala, J. Hakala, K. Ylihonko, and P. Mäntsälä
Elucidation of anthracyclinone biosynthesis by stepwise cloning of genes for anthracyclines from three different Streptomyces spp.
Microbiology, January 1, 2000; 146(1): 155 - 163.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1996 Society for General Microbiology.